ASPire To Win Provides Contract Research Organizations with Cost-Effective EDC and eCDM Capabilities to Increase Market Reach
ASPire To Win Provides Contract Research Organizations with Cost-Effective EDC and eCDM Capabilities to Increase Market Reach
New York, NY, April 4th, 2005 - Medidata Solutions Inc., a leading provider of electronic clinical data management solutions today announced ASPire To Win, the company's flagship partnership program for Contract Research Organizations (CROs). ASPire To Win is a non-exclusive, application service provider (ASP) partnership enabling CROs to implement and use Medidata RAVE for conducting electronic clinical trials. The program provides the training, certification and collaboration to equip CROs with the skills and capability to cost-effectively and professionally implement clinical trials using Medidata's electronic data capture (EDC) and electronic clinical data management (eCDM) technology.
Increasingly, drug sponsors require the use of EDC during clinical studies to streamline data collection and increase accuracy. This trend is growing as both drug sponsors and CROs have experienced the upside of EDC versus traditional paper-based approaches. Medidata has launched ASPire To Win to shift ASP service revenue related to EDC deployment away from the technology provider, and to the CRO that builds, implements, and manages the EDC study. During the sales cycle, CROs will benefit from adding EDC to their portfolio of services offerings; on the operations side, CROs will be knowledgeable and ready to implement EDC studies using Medidata RAVE.
"The ASPire To Win program leverages core competencies - our CRO partners will provide services and Medidata, an acknowledged leader in this field, will provide the intellectual property to support those services," said Dennis Cunningham, Senior Vice President of Strategic Alliances, Medidata. "ASPire To Win is a cost effective way for CROs to build a services business around Medidata RAVE's electronic data capture and electronic clinical data management technologies without any upfront technology transfer costs. We are experiencing significant adoption by CROs of Medidata's RAVE solution as both sponsors and CROs recognize the benefits of automation and our technology."
As part of the ASPire To Win program, CROs will be trained to build electronic Case Report Forms according to the study protocol and certified to implement EDC studies with full regulatory compliance. CROs will achieve core competency in edit specifications, outputs, data mining, and EDC administration, so that when a sponsor requests EDC in a clinical trial, certified CROs will be fully qualified to implement and manage electronic data capture using Medidata's industry-leading RAVE platform.
About Medidata Solutions
Medidata Solutions understands and helps clients manage the business of electronic clinical data management better than any one else. Designed to reduce the latency of information flow, optimize decision-making and improve resource allocation and safety, Medidata Solutions' flexible, enterprise-class workflow and web-based technology assists global life sciences and research organizations to accelerate the process of bringing life-enhancing treatments to market. Streamlined collection, verification, consolidation and analysis of clinical research data gives front line investigators, data managers and executives powerful tools to make more precise decisions earlier, reduce costs and drive efficiency. For more information about Medidata Solutions, visit www.mdsol.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.